TP53 and skin papilloma: Such activities explain an early paradoxical observation that WT p53 activity could support the development of carcinogen-induced skin papillomas in mice (Kemp et al. 1993) and several subsequent studies showing that retention of WT p53 can promote resistance to therapy (Ablain et al. 2016; Webster et al. 2020).